Careventures

Centogene AG is a leading genetic biotechnology company based in Rostock, Germany, specializing in genetic and biochemical diagnostic testing for rare hereditary disorders. The company offers a range of services to support the medical community, including genetic counseling, newborn screening, and biomarker analysis for lysosomal storage disorders. Centogene has developed a comprehensive rare disease platform that integrates epidemiologic, phenotypic, and genetic data, along with a biobank of blood samples, to aid in patient diagnosis and treatment. Additionally, the company collaborates with pharmaceutical partners to provide services such as patient recruitment, epidemiological insights, and biomarker discovery. Its diagnostic services are accessible through healthcare providers, facilitating targeted genetic sequencing for patients with various genetic disorders. With operations in multiple countries, including the United States and the United Arab Emirates, Centogene aims to improve awareness and treatment options for patients with rare diseases globally.

Corus is a supplier of dental solutions. They offer support during the daily treatment process, aligning the clinician expectation with those of the patient, by providing services that include digital flow, technical support for clients, logistics, the management of health products, management information, and high fidelity.

Qovetia brings together canine, equine, and rural veterinarians, willing to jointly develop their clinics around common values.

CENTOGENE is one of the largest genetic biotech companies worldwide, the European market leader, and one of the global leaders in genetic diagnostic analyses of rare inherited diseases. Transforming global genetic data into medical decisions, that are focused on creating broarder awareness for patients of all ethnicities around the world. CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients. With headquarters in Rostock, Germany and further operations in Berlin, Germany as well as Cambridge, Massachusetts, USA, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients with rare diseases and their families. CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis; it is active in research and is constantly developing new and innovative products for human genetics.